Joël Jean-Mairet

Joël Jean-Mairet has held various positions in the healthcare industry since 2007. In 2007, they were the Managing Partner and co-Founder of Ysios Capital. In 2012, they became the Chairman of the Board of Inbiomotion S.L. In 2015, they were a Director of Sanifit Laboratoris (now CSL) and Aura Biosciences (NASDAQ: AURA). In 2019, they were a Board Observer of AM-Pharma. In 2020, they were a Director of ONA Therapeutics, Splice Bio, and Lava Therapeutics B.V. (NASDAQ: LAVA). In 2021, they became a Director of Adcendo. In 2022, they became a Board Observer of Mineralys Therapeutics, Inc.

Joël Jean-Mairet earned a PhD and MSc in Biotechnology, Cell Biology, and Therapeutic Antibodies from the Eidgenössische Technische Hochschule Zürich between 1996 and 2001.